Genetic Testing 101: Identifying High Risk Individuals

Recorded Monday, September 28, 2015

In this webinar, the presenters discuss the role of genetic testing in the screening and treatment of high-risk individuals.

This webinars was hosted by the American Cancer Society in collaboration with the National Accreditation Program for Breast Centers (NAPBC).

Target Audience

Primary health care providers

Learning Objectives

  • Understand how to identify individuals at increased risk for breast cancer
  • Introduce some of the more common hereditary breast cancer syndromes
  • Examine the different genetic tests available as well as ideal genetic testing strategies
  • Explore management of women identified to be at high risk


For questions about the webinar, please contact

Course summary
Course opens: 
Course expires: 


J. Leonard Lichtenfeld, MD, MACP
Deputy Chief Medical Officer, American Cancer Society

Scott M. Weissman, MS, CGC
National Society of Genetic Counselors

About the Presenters

J. Leonard Lichtenfeld, MD, MACP

Dr. Lichtenfeld joined the American Cancer Society in 2001 and currently serves as Deputy Chief Medical Officer for the Society. A board certified medical oncologist and internist who was a practicing physician for more than 19 years, Dr. Lichtenfeld has long been engaged in health care policy on a local, state, and national level and currently serves on the board of the National Accreditation Program for Breast Centers.

Dr. Lichtenfeld is frequently quoted in the media regarding the American Cancer Society's positions on a number of important issues related to cancer and has testified regularly in legislative and regulatory hearings. He has participated on numerous panels regarding cancer care, research, advocacy, and related topics. Dr. Lichtenfeld is well known for his blog, Dr. Len’s Blog, which first appeared in 2005 and continues to address many topics related to cancer research and treatment.

Dr. Lichtenfeld is a graduate of the University of Pennsylvania and Hahnemann Medical College (now Drexel University College of Medicine) in Philadelphia. His postgraduate training was at Temple University Hospital in Philadelphia and Johns Hopkins University School of Medicine and the National Cancer Institute in Baltimore, MD. He is a member of the national Alpha Omega Alpha Honor Medical Society, and has been designated a Master of the American College of Physicians in acknowledgement of his contributions to internal medicine.

Scott M. Weissman, MS, CGC

Mr. Weissman is a certified genetic counselor, currently active in the National Society of Genetic Counselors (NSGC). He is a past co-chair of the Cancer Special Interest Group and is currently serving as the NSGC representative to the Commission on Cancer and National Accreditation Program for Breast Centers.

He graduated from the University of Illinois at Urbana-Champaign in 1998 with a BS in biology. After graduation, he spent two years at the Molecular Oncology Diagnostic Laboratory at the University of Illinois at Chicago developing expertise in molecular genetic techniques used in various hematologic and oncologic disorders. He completed the graduate program in Genetic Counseling at Northwestern University, Evanston, IL, in 2002 and provided adult and cancer genetic counseling at the Center for Medical Genetics in Evanston for 12 years. He joined GeneDx in 2013 and is currently an inherited cancer specialist working with hereditary cancer panels. 

This activity is not eligible for CME or CE credits.

Please login or register to take this course.